30 Sep 2022 --- AI-driven health-tech company Radicle Science and Open Book Extracts (OBX) have released the results of “history’s largest clinical trial researching CBD for sleep outcomes and the largest trial of cannabinol (CBN)-containing products.” The trial aimed to evaluate the effects of different CBD products relative to melatonin, finding that sleep length and quality improved when combined. NutritionInsight speaks with the CEOs of Radicle Science and OXB on the new findings and what it means for the industry.
